Inactive Instrument

Atrys Health, S.A. Share Price BME

Equities

ES0105148003

Healthcare Facilities & Services

Real-time Estimate Cboe Europe 16:15:17 21/05/2024 BST 5-day change 1st Jan Change
3.825 EUR -62.86% Intraday chart for Atrys Health, S.A. +4.04% +15.73%

Financials

Sales 2024 * 220M 239M 18.82B Sales 2025 * 236M 257M 20.2B Capitalization 292M 317M 24.97B
Net income 2024 * -2M -2.17M -171M Net income 2025 * 4M 4.34M 342M EV / Sales 2024 * 2.11 x
Net Debt 2024 * 173M 188M 14.79B Net Debt 2025 * 160M 174M 13.71B EV / Sales 2025 * 1.91 x
P/E ratio 2024 *
-117 x
P/E ratio 2025 *
70 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 48.57%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 12/06/07
Director of Finance/CFO - 31/07/15
Corporate Secretary - -
Members of the board TitleAgeSince
Director/Board Member 48 31/01/16
Director/Board Member - -
Director/Board Member 60 -
More insiders
Atrys Health SA, formerly Europath Biosciences SL, is Spain-based company primarily engaged in the predictive and personalized oncology therapies. It operates under Atrys brand name. Atrys is a clinical and translational research laboratory dedicated to the diagnosis, prognosis and treatment of cancer, including hematologic and solid malignancies. It has four areas of activity: Laboratory, Telemedicine, Radiotherapy, as well as Research and Development (R&D). The Company has its diagnostic laboratories and translational research in Barcelona and Granada, and offices in Madrid, Spain.
More about the company